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lieved to be critical for germ-layer-specific differentia-
tion. Furthermore, they note that among this class, ho-
meodomain proteins appear to be enriched. Though
the in silico analysis does not reveal whether protein
occupancy translates into control of the individual
targets identified, experimental evidence from other
studies indicates that OCT4 and SOX2 bind to and
function at the OCT4 and NANOG gene promoters in
more conventional assays (Kuroda et al., 2005; Oku-
mura-Nakanishi et al., 2005). On the other hand, it
should be kept in mind that protein occupancy is not
necessarily a predictor of action at a presumptive tar-
get gene (Zhang et al., 2005). Nonetheless, despite the
adage that transcription factor binding is not necessar-
ily equal to activity, it is probable that Boyer and col-
leagues (2005) have identified many of the biologically
relevant targets of OCT4, SOX2, and NANOG. Refined
experimental approaches are required to sift through
the candidates to assess whether gene activation or
repression is truly dependent on these factors.
Two simple regulatory network motifs are proposed
to account for the new data. A feedforward loop sug-
gests that OCT4 and SOX2 converge on the regulation
of NANOG, which, in turn, acts with these proteins to
control a vast array of downstream targets. This ar-
rangement allows for both stability and developmental
switching, depending on the activities and concentra-
tions of the individual factors themselves, and also sug-
gests that NANOG maintains a pivotal position in the
regulatory hierarchy. Consistent with the co-occupancy
of their promoters by the factors themselves, Boyer et
al. (2005) propose that OCT4, SOX2, and NANOG con-
form to an autoregulatory loop, which serves again to
maintain options of both stability and switching. In the
differentiation of tissue-specific lineages, regulatory
factors often operate in both positive and negative
fashions to refine the ultimate developmental decision
(Orkin, 2000). Here, too, it appears that the central fac-
tors OCT4, SOX2, and NANOG are likely to promote
expression of other pluripotency/self-renewal genes as
well as themselves, while simultaneously preventing
expression of differentiation-promoting genes. Their
actions are reinforced by the inhibitory effects of their
target pluripotency genes on differentiation (see Fig-
ure 1).
The elegant study of Boyer et al. (2005) is an initial
step in deciphering the network of transcription factors
that regulate ES cells. However, many important ques-
tions remain unanswered. Given the intricate network
apparent from the consideration of just three compo-
nents, we must ask how many other key pluripotency
factors with properties overlapping those of OCT4,
SOX2, and NANOG remain to be identified. If, as seems
likely, OCT4, SOX2, and NANOG can have either posi-
tive or negative effects on their target genes, how do
extracellular signals or other regulatory factors control
their transcriptional activities? Do cofactors for these
transcription factors further integrate aspects of the
regulatory network? What distinguishes those targets
that might be acted upon by one of these key regula-
tors (such as NANOG) in the absence of the others?
Looking ahead, the success of network dissection may
be judged by how well the insights gained allow manip-
ulation of somatic cells to adopt an ES cell identity. We
are just at the beginning of this journey. Given the com-
plexity of the preliminary roadmap there are likely to be
many detours along the way.
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A Skeleton of the Human
Protein Interactome
In this issue of Cell, Wanker and colleagues (Stelzl et
al., 2005) present a large-scale two-hybrid map of
more than 3000 putative human protein-protein in-
teractions. These new data will serve as an important
source of information regarding individual protein
partners and offer preliminary insight into the global
molecular organization of human cells.
Reductionist approaches have been remarkably suc-
cessful in helping biologists understand complex phe-
nomena by breaking down subjects into basic compo-
nents, such as the atoms that build proteins and the
genes that encode inherited traits. At the same time,
the human and other genome sequencing projects are
generating vast amounts of data that predict the exis-
tence of thousands of new gene products whose func-
tions and interrelationships we simply do not know. In
this context, how are we to progress from qualitative
descriptions of the constituent parts of biological sys-
tems toward an understanding of the properties that
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831define their real world dynamic behavior? Presumably,
it will require keeping track of both the forest and the
trees.
The overall molecular architecture of all organisms,
both structurally and functionally, is largely mediated
through elaborate scaffolds of protein-protein interac-
tions. The popular yeast two-hybrid screen has been
adapted to high-throughput experiments to describe
these protein “interactomes” (see Figure 1). The two-
hybrid assay is based on the transcription of reporter
genes following the interaction of pair-wise combina-
tions of ectopically expressed bait and prey in the yeast
nucleus. The first large-scale protein interaction studies
were in yeast (Uetz et al., 2000; Ito et al., 2001) but have
more recently been done in the fly (Giot et al., 2003)
and the worm (Li et al., 2004). The interactome field
now aspires to comprehensively describe human pro-
tein interaction networks. In a substantive first step to-
ward this goal, a two-hybrid study described in this
issue of Cell (Stelzl et al., 2005) identifies over 3000
candidate human protein interactions.
Prior to this study, the largest human two-hybrid
study reported 755 interactions, in a focused analysis
of TGFβ-regulated SMAD signaling pathways (Colland
et al., 2004). In both the Colland et al. (2004) and Stelzl
et al. (2005) studies, there are too many interactions to
validate individually. Both studies test the reliability of
their results using alternate experimental procedures.
Collard and coworkers used functional assays specific
to the pathways involved and siRNA knockdown exper-
iments to confirm 8 of 14 tested interactions. Stelzl et
al. (2005), on the other hand, used two types of bio-
chemical pull-down experiments to increase confidence
in their findings, confirming just over 60% of the 240
pair-wise interactions tested. They also go one step fur-
ther, developing a bioinformatics scoring system based
on heuristic reliability factors to sort the 3000 putative
interactions into sets with high, medium, and low confi-
dence. Factors that increase the confidence score forFigure 1. Four Views of the Human Inter-
actome
Binary protein interactions can be assessed
on a genome-wide scale and assembled into
large network topologies. Some of the protein
interactions in the interactome are stable as is
the case with many protein complexes (for
instance the proteasome) or transient as is
observed in many signaling pathways (such
as the MAPK signaling pathway). Transient
interactions are under-surveyed by most
large-scale experimental procedures aimed
at elucidating protein-protein interaction net-
works.any given interaction include the observation of a two-
hybrid signal with three different reporter genes, the in-
teraction found within 3- or 4-node reciprocal interac-
tion clusters or network cliques, the two interacting
proteins that share similar functional annotations in the
Gene Ontology Database, and the existence of pre-
viously identified orthologous interactions in yeast, fly,
or worm. Even though this scoring procedure presuma-
bly results in a bias of the high-confidence dataset to-
ward previously published interactions, it certainly adds
weight to the raw screen results and helps to justify
both additional experiments aimed at validating initial
findings and the testing of specific hypotheses regard-
ing protein function that logically extend from these ob-
servations.
Other large-scale proteomic studies using compre-
hensive methods of affinity tagging and purification, es-
pecially those performed using yeast as a model, have
been remarkably successful at identifying the compo-
nents of complexes (e.g., Butland et al., 2005). How-
ever, these methodical experimental screens typically
favor detection of static complexes because the tran-
sient, context-dependent nature of interactions in some
signaling pathways makes them more difficult to detect
(see Figure 1). As a consequence, many important in-
teractions may be missed in such screens. Indeed, a
recent in silico study provides a striking demonstration
that an unprecedented number of cellular processes
may be subject to regulation by “just-in-time assembly”
of protein complexes through differential expression of
only a few cognate subunits (de Lichtenberg et al.,
2005). Although increasingly effective proteomic meth-
ods are being developed for monitoring the transient
interactions in pathways under physiological conditions
on a genome-wide scale (Barrios-Rodiles et al., 2005),
elucidation of pathways often requires experimental
methods that detect genetic interactions rather than
those that detect physical ones. These alternative
methods include investigating epistasis, suppression or
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832rescue-of-function screens, and more recent procedures
for investigating genome-wide genetic interactions
(Tong et al., 2004).
The lack of reproducibility is the skeleton in the closet
for all high-throughput interaction studies. Indeed it is
fair to say that all of the high-throughput methods for
measuring protein interactions suffer from significant
false-positive and false-negative scoring (von Mering et
al., 2002). In fact, there is surprisingly little overlap in
the data generated by different detection methods,
suggesting that they are nonsaturating, erroneous, or
both. For these reasons, large-scale interaction studies
are frequently criticized. Another concern with two-
hybrid studies is whether the interactions detected are
biologically relevant given that they are assessed in
yeast nuclei, a nonphysiological milieu for cytoplasmic,
membrane, or nonendogenous proteins. This may ac-
count for the susceptibility of the two-hybrid assay to
false positives. Often, for unknown reasons, the assay
exhibits a considerable rate of false-positive detection,
perhaps because ectopic expression may lead to fortu-
itous binding or because of the natural randomness as-
sociated with mRNA expression (Raser and O’Shea,
2004). Missed interactions (false negatives) are another
concern. Moving past these apprehensions, a goal for
the future is to assemble the information from these
interactome studies into dynamic models of cellular
processes. As George Bernard Shaw wrote, “If you
cannot get rid of the family skeleton, you may as well
teach it to dance.”
Even though interactome studies would benefit from
efforts to improve or accelerate data validation, they
provide a valuable, previously unseen, view of a major
defining feature of cell biology—the protein interaction
network—from a global, systems-wide vantage. And
bioinformaticians have devised ingenious ways to deal
with the limitations of the core assays, principally by
combining datasets, but also through analysis of the
network properties of the interaction maps and projec-
tions of interactions across species. Intriguing, albeit
largely theoretical, observations have been made by
examining interaction datasets at different levels of ab-
straction (e.g., Kelley and Ideker, 2005). Yet many unan-
swered questions remain. How dynamic or hard-wired
are protein interaction networks? What is the relation-
ship of networks to cell phenotype or physiology? How
plastic are interaction networks across evolution? Con-
versely, to what extent does the evolution of protein
networks drive speciation? How does the modular or-
ganization of the protein networks in a cell contribute to
its overall interactome? And in light of the current study,
what features of the human interactome are unique?
In addition to representing a potentially rich source of
newly discovered interactions, the Stelzl et al. dataset
provides an intriguing glimpse of the far larger skeleton
of human protein interactions that is certain to exist.
This study and other imminent reports can help to re-
veal aspects of human biology that have been hidden
from traditional approaches. Based on what we learn
from these new perspectives, we may need to revisit
the issue of what is the appropriate unit for studying
human biology. Ultimately, it may not be the level of
protein complexes or pathways, or even phenotypes.
Instead, the full assembly of these interactions, both
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Denetic and physical, could produce a breakthrough in
nderstanding what it is to be human.
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